Skip to content

Role of Ayurveda medicine in Diabetese Complications

EFFICACY OF TRIPHALA-AMRTAADI KVATHA PANA IN THE MANAGEMENT OF DIABETIC RETINOPATHY- A RANDOMIZED CONTROLLED CLINICAL TRIAL

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/06/019721
Enrollment
20
Registered
2019-06-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H30-H36- Disorders of choroid and retina

Interventions

Intervention1: Triphala amrtaadi Kvatha: Triphala amrtaadi Kvatha will be given 50ml orally for 45 days Control Intervention1: Vasakadhi Kvatha : Vasakadhi Kvatha will be given 50ml orally for 45 day

Sponsors

KAHERs Shri BMK Ayurveda Mahavidyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with clinically established condition of Diabetic Retinopathy Patients with Non proliferative diabetic retinopathy of mild to moderate changes Patients of DM (Type 1&Type 2) between the ages 20-70years having ophthalmoscopically detectable DR changes. Patients on anti diabetic treatment and good glycemic control.

Exclusion criteria

Exclusion criteria: Patient with Severe NPDR, proliferative diabetic retinopathy, high risk proliferative diabetic retinopathy, Diabetic maculopathy, advanced diabetic eye disease, and retinopathies of other origin will be excluded. Known patients of Glaucoma and any ophthalmic infective conditions will be excluded. Patients with Aided Visual Acuity less than 6/60 at Snellenâ??s distant chart. Patients with other systemic disorders like renal diseases, chronic uncontrolled hyperglycaemia and hyperlipidaemia, cardiovascular diseases etc will be excluded. Extremely debilitated patients and in pregnancy .

Design outcomes

Primary

MeasureTime frame
Triphalaamrtaadi Kvathapana if proved more efficacious would help in treating Diabetic Retinopathy more efficiently. Timepoint: oth, 15th, 30th, 46th Day

Secondary

MeasureTime frame
NOT APPLICABLETimepoint: NOT APPLICABLE

Countries

India

Contacts

Public ContactDR MEGHANA B PATIL

KAHERâ??s Shri BMK Ayurveda Mahavidyalaya

megs816@gmail.com9916871886

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026